BPTH — Bio Path Holdings Cashflow Statement
0.000.00%
Last trade - 00:00
- $3.23m
- $2.18m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -8.6 | -10.9 | -10.4 | -13.9 | -16.1 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 0.78 | 0.656 | 0.906 | 0.941 | 1.1 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.676 | -0.806 | -0.459 | -2.26 | 3.36 |
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | -8.36 | -11 | -9.92 | -15.1 | -11.5 |
Capital Expenditures | 0 | — | -0.07 | -0.021 | — |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | 0 | — | -0.07 | -0.021 | — |
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 27.8 | 4.29 | 20 | 1.73 | 2.2 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 19.4 | -6.67 | 10 | -13.4 | -9.33 |